Two hunger signals, one weekly shot.
Tirzepatide is a dual-action medication that mimics two natural gut hormones, GLP-1 and GIP, which regulate appetite, fullness, and blood sugar. Acting on both pathways quiets "food noise" and helps you feel satisfied with less. In clinical trials, people on the highest doses lost about 20% of their body weight on average. The 3-month program gets you started or keeps you moving, with medical supervision throughout.
Quick benefits
Dual-hormone action — targets GLP-1 and GIP for stronger appetite control.
Once weekly — one simple injection a week.
Dose that fits you — low dose for starting out, high dose for continuing patients.
Medically supervised — eligibility, dosing, and check-ins by a licensed provider.
Best for: new patients starting GLP-1 therapy, patients ready to step up their dose, and anyone wanting the strongest appetite support.